Department of Biosystems Science and Engineering, ETH Zürich, CH-4058 Basel, Switzerland; email:
Annu Rev Pharmacol Toxicol. 2014;54:227-49. doi: 10.1146/annurev-pharmtox-011613-135921. Epub 2013 Oct 11.
G protein-coupled receptors (GPCRs) mediate the majority of cellular responses to hormones and neurotransmitters within the human body. They have much potential in the emerging field of synthetic biology, which is the rational, systematic design of biological systems with desired functionality. The responsiveness of GPCRs to a plethora of endogenous and exogenous ligands and stimuli make them ideal sensory receptor modules of synthetic gene networks. Such networks can activate target gene expression in response to a specific stimulus. Additionally, because GPCRs are important pharmacological targets of various human diseases, genes encoding their protein/peptide ligands can also be incorporated as target genes of the response output elements of synthetic gene networks. This review aims to critically examine the potential role of GPCRs in constructing therapeutic synthetic gene networks and to discuss various challenges in utilizing GPCRs for synthetic biology applications.
G 蛋白偶联受体 (GPCRs) 在人体内介导了大多数细胞对激素和神经递质的反应。它们在新兴的合成生物学领域具有很大的潜力,合成生物学是对具有所需功能的生物系统进行合理、系统的设计。GPCR 对大量内源性和外源性配体和刺激物的反应使它们成为合成基因网络理想的感应受体模块。这样的网络可以在响应特定刺激时激活目标基因的表达。此外,由于 GPCR 是各种人类疾病的重要药理学靶点,编码其蛋白质/肽配体的基因也可以作为合成基因网络的响应输出元件的靶基因。本文旨在批判性地探讨 GPCR 在构建治疗性合成基因网络中的潜在作用,并讨论在利用 GPCR 进行合成生物学应用时所面临的各种挑战。